Results 171 to 180 of about 5,003 (295)

Cooperative SIR dynamics as a model for spontaneous blood clot initiation [PDF]

arXiv
Blood clotting is an important physiological process to suppress bleeding upon injury, but when it occurs inadvertently, it can cause thrombosis, which can lead to life threatening conditions. Hence, understanding the microscopic mechanistic factors for inadvertent, spontaneous blood clotting, in absence of a vessel breach, can help in predicting and ...
arxiv  

FIRST CASE OF PLATELET-TRANSFUSION REFRACTORINESS CAUSED BY HPA-6b ANTIBODY Reported IN JAPAN

, 2003
Michiko Iwamoto, K Ichimura, Kazuhito Uchida, Hiroko Shima, Toyohiko Adachi, Atsuko Taniue, Yasuo Fukumori, Nobuo Nagao, Yoichi Shibata, T Hayashi   +9 more
openalex   +2 more sources

CHANGE IN THE KINETICS OF PLATELET TRANSFUSION IN A PATIENT RECEIVING COMBINATION THERAPY WITH HIGH-DOSE INTRAVENOUS GAMMA GLOBULIN AND SPLENECTOMY: IMPROVEMENT IN REFRACTORINESS TO PLATELET TRANSFUSION

, 2004
Nobuyuki Yoshio
openalex   +2 more sources

A case of platelet transfusion refractoriness occurring after platelet transfusion for tooth extraction

, 2015
Hirokazu Tanaka, Kenji Kurashina, Kiyonori Hayashi, Rishiho Nishizawa, Hideki Miyazawa, Hiroshi Kurita   +5 more
openalex   +2 more sources

Occurence and dynamics of HLA and HPA antibodies in the setting of matched related HSCT [PDF]

, 2018
Bräutigam, Michelle, Buser, Andreas, Drexler, Beatrice, Halter, Jörg, Heim, Dominik, Holbro, Andreas, Infanti, Laura, Passweg, Jakob R, Plattner, Alexandra, Volken, Thomas   +9 more
core   +1 more source

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia. [PDF]

Cancer Med, 2020
Hu X, Cai H, Zheng L, Luo Y, Zhou J, Hui Y, Dai Z, Lin H, Li D, Xiao Y, Huang L, Zhou J.   +11 more
europepmc   +1 more source

A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact on Clinical Refractoriness

, 2018
Laurence Corash, Joycelyn Sim, Wai‐Chiu Tsoi, Cheuk Kwong Lee, Rock Y. Y. Leung, Yingjie Liu, Norman Huang, Clarence Lam, Hans Vermeij, Adonis Stassinopoulos, Richard J. Benjamin, Albert Kwok Wai Lie   +11 more
openalex   +1 more source

Results of the prematurely terminated TEMPLE randomized controlled trial in patients with myelodysplastic syndrome: liberal versus restrictive red blood cell transfusion threshold [PDF]

, 2020
Beckers, E.A.M. (Erik), Boekhorst, P.A.W. (Peter) te, Gerard Jansen, A.J. (A. J.), Schipperus, M.R. (Martin), Van Den Bosch, J. (Joan)   +4 more
core   +1 more source

A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients. [PDF]

Br J Haematol, 2020
Vo P, Purev E, West KA, McDuffee E, Worthy T, Cook L, Hawks G, Wells B, Shalabi R, Flegel WA, Adams SD, Reger R, Aue G, Tian X, Childs R.   +14 more
europepmc   +1 more source

Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia

Vascular Health and Risk Management, 2007
Man-Chiu PoonDepartments of Medicine, Pediatrics and Oncology and Southern Alberta Bleeding Disorders Clinic, University of Calgary and Calgary Health Region, Calgary, Alberta, CanadaAbstract: Glanzmann’s thrombasthenia (GT) is a congenital ...
Man-Chiu Poon
doaj